主页
帮助中心客户支持COASDS 登录/注册 订单 (0)
搜索 (0)
当前位置:首页 > 产品 > 生命科学 > 酶学 >Thalidomide, 98%, initially promoted as a sedative, inhibits cereblon (CRBN), with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties
  • Thalidomide, 98%, initially promoted as a sedative, inhibits cereblon (CRBN), with a Kd of ∼250 nM, and has immunomodulatory, anti-inflammatory and anti-angiogenic cancer properties
    沙利度胺
    MW : 258.23 CAS : 50-35-1 EC号 : 258.23 MDL号 : MFCD00153873
    货号（SKU）
    包装规格
    库存
    价格
    数量
    1G
    现价: ¥50.00
    100G
    现价: ¥2530.00
    25G
    现价: ¥764.00
    现价: ¥20.00
    5g
    现价: ¥163.00
基础信息

  • MF

    C13H10N2O4

  • MW

    258.23

  • Synonymity

    (±)-2-(2,6-Dioxo-3-piperidinyl)-1H-isoindole-1,3(2H)-dione

  • MP

    266-270

  • MPmmHg

    760

  • BPmmHg

    760

  • FPmmHg

    760

  • FPMeasurement

    C.C

  • DensityUnit

    g/mL

  • DensityCelsius

    25

  • MDL

    MFCD00153873

  • EINECS

    200-031-1

  • SpecialRequirement

    Freezer -20℃

  • Hazard

    LHLSLT

  • RiskSign

    Danger

  • HValue

    H301 H312 H361

  • PValue

    P280 P301+P310

  • UN

    2811

  • HazardClass

    6.1

  • PackingG

    III

  • WGK

    3

  • RTECS

    TI4375000

  • TSCA

    0

相关文档
质检报告COA
搜索
相关产品